What is the 13F Pro Quality Score for AMS?

13F Pro ranks AMERICAN SHARED HOSPITAL SERVICES (AMS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View AMS's current score at https://13fpro.ai/company/AMS (free sign-up required for the full ranking).

Where does 13F Pro source AMS data?

All AMERICAN SHARED HOSPITAL SERVICES fundamentals and ownership data come directly from SEC EDGAR. AMERICAN SHARED HOSPITAL SERVICES files with the SEC under CIK 744825. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is AMS in?

AMERICAN SHARED HOSPITAL SERVICES (AMS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives AMS's revenue?

Per AMERICAN SHARED HOSPITAL SERVICES's latest 10-Q filed with the SEC on 2026-08-13, the biggest revenue drivers are: Leasing (medical equipment) ($3.545M, -0.7% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/AMS.

How often is AMS research updated on 13F Pro?

AMS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

AMERICAN SHARED HOSPITAL SERVICES(AMS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSEsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 744825 AMS stock profile & AI dashboard →

13F Pro Quality Score

44.7/100

Rank #1,904 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

71.4/100

Profitability

28.4/100

Balance Sheet

26.4/100

Earnings Quality

89.7/100

Free Cash Flow

59.1/100

Institutional Flow

6.0/100

Revenue Scale

5.2/100

Dilution Risk

47.5/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why AMS Scores 45/100

exact factor attribution · 2026-09-11

AMS's composite is driven by revenue growth and earnings quality, held back by scale and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+4.3 pts

71th pct

Earnings quality

+4.0 pts

90th pct

Free cash flow

+1.4 pts

59th pct

Shareholder dilution

-0.1 pts

48th pct

Earnings growth

-0.3 pts

45th pct

Institutional flow

-2.2 pts

6th pct

Capital efficiency

-2.4 pts

26th pct

Profitability

-3.2 pts

28th pct

Scale

-6.7 pts

5th pct

Latest change (2026-08-13): 34 → 41 · ↑ Free cash flow 17→77; despite ↓ Revenue growth 74→58

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

AMS Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for AMERICAN SHARED HOSPITAL SERVICES (AMS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AMS at 44.7/100 on a 32-signal composite quality model, placing it at rank #1,904 of 2,961 stocks — the bottom half of the AI-ranked universe. AMS scores in the top quartile across earnings quality (89.7). Areas of concern include revenue scale (5.2) and institutional flow (6.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AMERICAN SHARED HOSPITAL SERVICES reports quarterly revenue of $8.4M, net income of $-514.0K, an operating margin of -10.8%. Top institutional holders of AMS by reported 13-F value include DIMENSIONAL FUND ADVISORS, LPL Financial, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. AMS trades on the NYSE exchange and files with the SEC under CIK 744825. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AMERICAN SHARED HOSPITAL SERVICES directly from SEC EDGAR. AMERICAN SHARED HOSPITAL SERVICES's 13F Pro composite quality score has ranged between 34 and 51 since 2025, currently 44.7 — a declining long-term trajectory across 51 quarterly and live scoring snapshots.

What's Driving AMS's Business? Latest 10-Q Breakdown

AI-extracted from AMERICAN SHARED HOSPITAL SERVICES's 10-Q filed 2026-08-13 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Biggest Revenue Drivers

Leasing (medical equipment)$3.545M-0.7% YoY

Lower Gamma Knife procedures offset by higher PBRT revenues; PBRT revenues increased $425K driven by higher volumes and reimbursement.

Biggest Revenue Drivers

Leasing (medical equipment)$3.545M-0.7% YoY

Lower Gamma Knife procedures offset by higher PBRT revenues; PBRT revenues increased $425K driven by higher volumes and reimbursement.

Largest Expense Items

Depreciation and amortization$1.341M-10.4% YoY

Expiration of Gamma Knife customer contract in April 2025 and change in PBRT equipment useful life estimate; partially offset by Gamma Knife Peru upgrade depreciation.

Margins: Gross margin compressed to $1.433M (17.0% of revenue) from $1.630M (23.0%) YoY, primarily due to significantly higher operating costs at direct patient services facilities and a $909K allowance increase for credit losses at Rhode Island facilities, offset partially by higher-margin PBRT revenues.

Watch Items from the Filing

Going concern uncertainty: Company failed April 9, 2026 debt maturity, breached multiple loan covenants (minimum cash, debt-to-EBITDA, fixed-charge coverage), and obtained forbearance through June 30, 2027. Lender can accelerate $16.2M outstanding debt at any time.
Third Amendment to Credit Agreement (July 22, 2026) requires Company to pursue asset sale, achieve sale milestones, and pay penalties if milestones unmet; all obligations due June 30, 2027.
Rhode Island facilities credit quality deterioration: $909K allowance increase on $7.466M ASC 606 accounts receivable (13% allowance); facility payment terms net 30–60 days suggest collection challenges.
Subordinated $2M promissory note from Executive Chairman (July 22, 2026) at 10% interest, due July 21, 2027, with 220K warrant at $1.45/share; indicates tight liquidity and founder support dependency.
Leasing segment Gamma Knife procedures declined 11.3% YoY; one customer contract expired April 2025. Direct patient services international Gamma Knife volumes grew 46.7% but subject to local government/economic fluctuations.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$8.4M

Net Income

Q2 2026

$-514.0K

Free Cash Flow

Q2 2026

$2.2M

Operating Margin

Q2 2026

-10.8%

ROIC

Q2 2026

-6.6%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-0.9% YoY

$28.1MFY 2025

FY22 $19.7MFY23 $21.3MFY24 $28.3MFY25 $28.1M

Net Income

-171.0% YoY

$-1.6MFY 2025

FY22 $1.3MFY23 $610.0KFY24 $2.2MFY25 $-1.6M

Operating Income

-27.9% YoY

$-3.6MFY 2025

FY22 $2.4MFY23 $270.0KFY24 $-2.8MFY25 $-3.6M

EPS (Diluted)

-169.7% YoY

$-0.23FY 2025

FY22 $0.21FY23 $0.10FY24 $0.33FY25 $-0.23

Total Assets

-7.8% YoY

$55.5MFY 2025

FY22 $44.0MFY23 $48.2MFY24 $60.2MFY25 $55.5M

Total Debt

+49.2% YoY

$34.7MFY 2025

FY22 $14.9MFY23 $15.4MFY24 $23.3MFY25 $34.7M

Op. Cash Flow

+1755.1% YoY

$3.1MFY 2025

FY22 $7.2MFY23 $5.7MFY24 $167.0KFY25 $3.1M

Free Cash Flow

+41.6% YoY

$-4.5MFY 2025

FY22 $6.8MFY23 $-555.0KFY24 $-7.8MFY25 $-4.5M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$28.1M -0.9%	$28.3M +32.9%	$21.3M +8.0%	$19.7M +12.0%	$17.6M -1.2%	$17.8M
Net Income	$-1.6M -171.0%	$2.2M +258.4%	$610.0K -54.1%	$1.3M +584.5%	$194.0K +102.7%	$-7.1M
Operating Income	$-3.6M -27.9%	$-2.8M -1138.9%	$270.0K -88.9%	$2.4M +79.9%	$1.4M +114.3%	$-9.5M
EPS (Diluted)	$-0.23 -169.7%	$0.33 +230.0%	$0.10 -52.4%	$0.21 +600.0%	$0.03 +102.6%	$-1.14
Total Assets	$55.5M -7.8%	$60.2M +25.0%	$48.2M +9.6%	$44.0M -3.2%	$45.4M +4.1%	$43.7M
Total Debt	$34.7M +49.2%	$23.3M +51.3%	$15.4M +3.0%	$14.9M -11.0%	$16.8M +168.4%	$6.3M
Operating Cash Flow	$3.1M +1755.1%	$167.0K -97.1%	$5.7M -21.0%	$7.2M +15.4%	$6.3M -35.7%	$9.7M
Free Cash Flow	$-4.5M +41.6%	$-7.8M -1300.2%	$-555.0K -108.1%	$6.8M +49.1%	$4.6M -50.6%	$9.3M

Get alerted when AMS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for AMERICAN SHARED HOSPITAL SERVICES including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of AMS

DIMENSIONAL FUND ADVISORS LP
$161.4K102,140 sh
LPL Financial LLC
$128.6K81,386 sh
RENAISSANCE TECHNOLOGIES LLC
$91.2K57,695 sh
VANGUARD CAPITAL MANAGEMENT LLC
$87.9K55,662 sh
NewEdge Advisors, LLC
$47.0K29,725 sh
JAMES INVESTMENT RESEARCH, INC.
$47.0K29,725 sh
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$46.0K29,124 sh
GEODE CAPITAL MANAGEMENT, LLC
$41.9K26,497 sh
VANGUARD FIDUCIARY TRUST CO
$40.1K25,363 sh
XTX Topco Ltd
$30.2K19,107 sh

Fund	Value	Shares
DIMENSIONAL FUND ADVISORS LP	$161.4K	102,140
LPL Financial LLC	$128.6K	81,386
RENAISSANCE TECHNOLOGIES LLC	$91.2K	57,695
VANGUARD CAPITAL MANAGEMENT LLC	$87.9K	55,662
NewEdge Advisors, LLC	$47.0K	29,725
JAMES INVESTMENT RESEARCH, INC.	$47.0K	29,725
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$46.0K	29,124
GEODE CAPITAL MANAGEMENT, LLC	$41.9K	26,497
VANGUARD FIDUCIARY TRUST CO	$40.1K	25,363
XTX Topco Ltd	$30.2K	19,107

Companies Similar to AMS

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

KOSS

KOSS CORP

AI score

Very similar · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

APT

ALPHA PRO TECH LTD

AI score

Very similar · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

CBAT.R1117171

CBAK Energy Technology, Inc.

AI score

Very similar · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

NAII

NATURAL ALTERNATIVES INTERNATIONAL INC

AI score

Very similar · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

WVVI

WILLAMETTE VALLEY VINEYARDS INC

AI score

Shared smart-money ownership · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

MHH

Mastech Digital, Inc.

AI score

Shared smart-money ownership · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

TRT

TRIO-TECH INTERNATIONAL

AI score

Shared smart-money ownership · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

EBS

Emergent BioSolutions Inc.

AI score

Similar quality profile · 1 shared holders

JAMES INVESTMENT RESEARCH, INC.

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put AMS on your watchlist

Track score changes the day AMERICAN SHARED HOSPITAL SERVICES files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is AMS a good stock to buy?

13F Pro's AI-powered analysis of AMERICAN SHARED HOSPITAL SERVICES (AMS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AMS are available on the AMS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. AMS is classified as a small company.

Which hedge funds own AMS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AMS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AMERICAN SHARED HOSPITAL SERVICES's investment landscape.